Stephens & Co. Reiterates Overweight on Ardent Health Partners, Maintains $24 Price Target
Portfolio Pulse from Benzinga Newsdesk
Stephens & Co. analyst Scott Fidel has reiterated an Overweight rating on Ardent Health Partners (NYSE:ARDT) and maintained a $24 price target.
August 15, 2024 | 12:37 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Stephens & Co. analyst Scott Fidel has reiterated an Overweight rating on Ardent Health Partners (NYSE:ARDT) and maintained a $24 price target.
The reiteration of an Overweight rating and the maintenance of a $24 price target by a reputable analyst can positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100